MFS
ITOS

Mirabella Financial Services’s iTeos Therapeutics ITOS Stock Holding History

Mirabella Financial Services’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-14,280
Closed -$386K – 507
2021
Q3 		$386K Buy
+14,280
New +$373K 0.05% 276

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirabella Financial Services's ITOS Position: Q4 2021 in Review

Mirabella Financial Services sold out of iTeos Therapeutics (ITOS) in Q4 2021, closing a stake of 14,280 shares — an estimated $386K sold.

Mirabella Financial Services first reported a position in ITOS in Q3 2021 and held it in 1 quarter. The position peaked at $386K in Q3 2021. 118 funds tracked by Wall St. Rank hold ITOS as of Q4 2021.

  • Mirabella Financial Services reported no remaining iTeos Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Mirabella Financial Services sold 14,280 iTeos Therapeutics shares in Q4 2021, an estimated $386K.
  • Mirabella Financial Services first reported a position in iTeos Therapeutics in Q3 2021 and held it in 1 quarter.
  • Mirabella Financial Services's iTeos Therapeutics position peaked at $386K in Q3 2021.
  • 118 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2021.

Based on Mirabella Financial Services's 13F filing for Q4 2021, filed 14 Feb 2022.